{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T18:03:36Z","timestamp":1793556216756,"version":"4.5.0"},"reference-count":309,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T00:00:00Z","timestamp":1747094400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>The global prevalence of inflammatory bowel disease (IBD) has significantly increased in recent decades. IBD is a long-term, recurring, gastrointestinal inflammatory condition that mainly comprises two primary clinical types: ulcerative colitis and Crohn\u2019s disease. The current treatment paradigm for IBD primarily focuses on symptom management. However, this approach does not support mucosal epithelial repair, maintenance of barrier homeostasis, or regulation of biological functions in the gut. Conventional therapies rely on the frequent use of high-dose medications, including antibiotics, nonsteroidal anti-inflammatory drugs, biological agents, and immunomodulators. Recently, mesenchymal stem\/stromal cells (MSCs) have gained interest in tissue regeneration owing to their unique ability to differentiate and secrete regulatory factors, including extracellular vesicles (EVs), which play crucial roles in abnormal organization. Various routes of administration have been explored in preclinical and clinical studies to deliver MSCs from diverse tissue sources. The routes include intraperitoneal, intravenous, and local (intracolonic or rectal) delivery. The MSCs employed were obtained from various tissues, including bone marrow, umbilical cord, and adipose tissue. This article reviews the research framework for the application of MSCs and EVs secretion in the treatment of IBD, emphasizing key immunological effects, such as immune microenvironment regulation, intestinal barrier stabilization, and therapeutic approaches targeting intestinal barrier disorders. The discussion primarily focuses on the advantages of MSCs over other biologics, impairment of gut mucosal tissue-resident mesenchymal stem cells in IBD development, immune targets (at the cellular and molecular levels) within the framework of IBD, and the reparative effects of MSCs in the microenvironment of IBD. We aimed to present an overview of the current trends in MSC research and therapy, as well as to identify the challenges and future directions that must be addressed to advance research on MSC-mediated therapeutic strategies for IBD.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1543702","type":"journal-article","created":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T05:30:45Z","timestamp":1747114245000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":16,"title":["\u201cRemodeling the intestinal immune microenvironment\u201d: immune regulation and tissue regeneration by mesenchymal stem\/stromal cells in the repair microenvironment of inflammatory bowel disease"],"prefix":"10.3389","volume":"16","author":[{"given":"Hongkun","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simin","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinghan","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingyan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,5,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/j.immuni.2019.03.017","article-title":"Cytokine networks in the pathophysiology of inflammatory bowel disease","volume":"50","author":"Friedrich","year":"2019","journal-title":"Immunity"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2015.150","article-title":"The global burden of ibd: from 2015 to 2025","volume":"12","author":"Kaplan","year":"2015","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2015.1982","article-title":"Inflammatory bowel disease in children and adolescents","volume":"169","author":"Rosen","year":"2015","journal-title":"JAMA Pediatr"},{"key":"B4","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1053\/j.gastro.2023.03.238","article-title":"Defining interactions between the genome, epigenome, and the environment in inflammatory bowel disease: progress and prospects","volume":"165","author":"Noble","year":"2023","journal-title":"Gastroenterology"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddz189","article-title":"Rare and common variant discovery in complex disease: the Ibd case study","volume":"28","author":"Venkataraman","year":"2019","journal-title":"Hum Mol Genet"},{"key":"B6","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/nrgastro.2017.136","article-title":"Environmental triggers in Ibd: A review of progress and evidence","volume":"15","author":"Ananthakrishnan","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2015.34","article-title":"Epidemiology and risk factors for Ibd","volume":"12","author":"Ananthakrishnan","year":"2015","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1177\/2050640619852244","article-title":"Dietary risk factors for inflammatory bowel diseases in a high-risk population: results from the faroese Ibd study","volume":"7","author":"Hammer","year":"2019","journal-title":"U Eur Gastroenterol J"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2014.182","article-title":"Ibd: global variations in environmental risk factors for Ibd","volume":"11","author":"Kaplan","year":"2014","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1097\/mib.0000000000000602","article-title":"Gut microbiota dysbiosis as risk and premorbid factors of ibd and Ibs along the childhood-adulthood transition","volume":"22","author":"Putignani","year":"2016","journal-title":"Inflammation Bowel Dis"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2023.01.001","article-title":"Ibd disease-modifying therapies: insights from emerging therapeutics","volume":"29","author":"Kotla","year":"2023","journal-title":"Trends Mol Med"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2021.107859","article-title":"Soluble ligands as drug targets for treatment of inflammatory bowel disease","volume":"226","author":"Tong","year":"2021","journal-title":"Pharmacol Ther"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2017.110","article-title":"The Ibd interactome: an integrated view of aetiology, pathogenesis and therapy","volume":"14","author":"de Souza","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12950-020-00246-4","article-title":"Ulcerative colitis: understanding its cellular pathology could provide insights into novel therapies","volume":"17","author":"Kaur","year":"2020","journal-title":"J Inflammation (Lond)"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1038\/ajg.2013.203","article-title":"Colorectal cancer in Ibd patients","volume":"108","author":"Stormont","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.revinf.2013.12.011","article-title":"Ibd and increased risk of cancer: what is the reality]","author":"Beaugerie","year":"2014","journal-title":"Rev Infirm"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2021.07.042","article-title":"Extraintestinal manifestations of inflammatory bowel disease: current concepts, treatment, and implications for disease management","volume":"161","author":"Rogler","year":"2021","journal-title":"Gastroenterology"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2021.08.032","article-title":"Prevalence of primary sclerosing cholangitis in patients with inflammatory bowel disease: A systematic review and meta-analysis","volume":"161","author":"Barberio","year":"2021","journal-title":"Gastroenterology"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.7499\/j.issn.1008-8830.1911125","article-title":"Extraintestinal manifestations and intestinal complications in children with crohn\u2019s disease: an analysis of 54 cases","volume":"22","author":"Tang","year":"2020","journal-title":"Zhongguo Dang Dai Er Ke Za Zhi"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-019-0415-0","article-title":"Targeting immune cell circuits and trafficking in inflammatory bowel disease","volume":"20","author":"Neurath","year":"2019","journal-title":"Nat Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1007\/s11938-017-0130-6","article-title":"Treat to target in inflammatory bowel disease: an updated review of literature","volume":"15","author":"Darr","year":"2017","journal-title":"Curr Treat Options Gastroenterol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"xvii","DOI":"10.1016\/j.suc.2019.08.016","article-title":"Inflammatory bowel disease","volume":"99","author":"Langenfeld","year":"2019","journal-title":"Surg Clin North Am"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2008.03915.x","article-title":"Systematic review: does concurrent therapy with 5-asa and immunomodulators in inflammatory bowel disease improve outcomes","volume":"29","author":"Andrews","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"B24","doi-asserted-by":"publisher","first-page":"Cd000296","DOI":"10.1002\/14651858.CD000296.pub4","article-title":"Budesonide for induction of remission in Crohn\u2019s disease","volume":"2015","author":"Rezaie","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/s2468-1253(22)00385-5","article-title":"Withdrawal of infliximab or concomitant immunosuppressant therapy in patients with Crohn\u2019s disease on combination therapy (Spare): A multicentre, open-label, randomised controlled trial","volume":"8","author":"Louis","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2021.10.037","article-title":"Efficacy of biologic drugs in short-duration versus long-duration inflammatory bowel disease: A systematic review and an individual-patient data meta-analysis of randomized controlled trials","volume":"162","author":"Ben-Horin","year":"2022","journal-title":"Gastroenterology"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjab232.491","article-title":"P364 comparison of two treatment strategies in Ibd: biosimilar adalimumab (Cinnora\u00ae) in monotherapy and in combination with azathioprine","volume":"16","author":"AlborziAvanaki","year":"2022","journal-title":"J Crohn\u2019s Colitis"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.3390\/nu13051628","article-title":"Nutritional treatment in Crohn\u2019s disease","volume":"13","author":"Caio","year":"2021","journal-title":"Nutrients"},{"key":"B29","doi-asserted-by":"publisher","first-page":"384","DOI":"10.14309\/ajg.0000000000000152","article-title":"Acg clinical guideline: ulcerative colitis in adults","volume":"114","author":"Rubin","year":"2019","journal-title":"Am J Gastroenterol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2020.12.031","article-title":"Stride-ii: an update on the selecting therapeutic targets in inflammatory bowel disease (Stride) initiative of the international organization for the study of ibd (Ioibd): determining therapeutic goals for treat-to-target strategies in Ibd","volume":"160","author":"Turner","year":"2021","journal-title":"Gastroenterology"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1159\/000540421","article-title":"Antibodies targeting the tumor necrosis factor-like ligand 1a in inflammatory bowel disease: A new kid on the (Biologics) block","volume":"105","author":"Schweckendiek","year":"2024","journal-title":"Digestion"},{"key":"B32","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.3390\/ijms18102020","article-title":"The innate and adaptive immune system as targets for biologic therapies in inflammatory bowel disease","volume":"18","author":"Holleran","year":"2017","journal-title":"Int J Mol Sci"},{"key":"B33","doi-asserted-by":"publisher","first-page":"189","DOI":"10.3390\/biologics1020012","article-title":"Biological treatments in inflammatory bowel disease: A complex mix of mechanisms and actions","volume":"1","author":"Moreno","year":"2021","journal-title":"Biologics"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpg.2021.101759","article-title":"Immunosuppressants and immune modulators in luminal gastroenterology","author":"Forbes","year":"2021","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1016\/j.cgh.2020.02.009","article-title":"Predicting, preventing, and managing treatment-related complications in patients with inflammatory bowel diseases","volume":"18","author":"Beaugerie","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1097\/mib.0000000000001261","article-title":"Safety considerations with the use of corticosteroids and biologic therapies in mild-to-moderate ulcerative colitis","volume":"23","author":"Cross","year":"2017","journal-title":"Inflammation Bowel Dis"},{"key":"B37","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s00535-024-02086-y","article-title":"Change in systemic steroid use and surgery rate in patients with inflammatory bowel disease: A Japanese real-world database analysis","volume":"59","author":"Hirayama","year":"2024","journal-title":"J Gastroenterol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1080\/1744666x.2019.1630273","article-title":"Therapeutic drug monitoring with biologic agents in immune mediated inflammatory diseases","volume":"15","author":"Papamichael","year":"2019","journal-title":"Expert Rev Clin Immunol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/j.1365-2125.2010.03760.x","article-title":"Appropriate infliximab infusion dosage and monitoring: results of a panel meeting of rheumatologists, dermatologists and gastroenterologists","volume":"71","author":"de Vries","year":"2011","journal-title":"Br J Clin Pharmacol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2015.05.022","article-title":"Prevalence of antibodies against jc virus in patients with refractory Crohn\u2019s disease and effects of natalizumab therapy","volume":"13","author":"Bellaguarda","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa050516","article-title":"Infliximab for induction and maintenance therapy for ulcerative colitis","volume":"353","author":"Rutgeerts","year":"2005","journal-title":"N Engl J Med"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1111\/apt.13475","article-title":"Systematic review with meta-analysis: mucosal healing is associated with improved long-term outcomes in Crohn\u2019s disease","volume":"43","author":"Shah","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1056\/nejm199905063401804","article-title":"Infliximab for the treatment of fistulas in patients with Crohn\u2019s disease","volume":"340","author":"Present","year":"1999","journal-title":"N Engl J Med"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/s2468-1253(21)00312-5","article-title":"Comparative efficacy and safety of biologic therapies for moderate-to-severe Crohn\u2019s disease: A systematic review and network meta-analysis","volume":"6","author":"Singh","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1038\/ctg.2016.24","article-title":"Maintenance of efficacy and continuing safety of golimumab for active ulcerative colitis: pursuit-sc maintenance study extension through 1 year","volume":"7","author":"Gibson","year":"2016","journal-title":"Clin Transl Gastroenterol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2011.04682.x","article-title":"Severe infusion reactions to infliximab: aetiology, immunogenicity and risk factors in patients with inflammatory bowel disease","volume":"34","author":"Steenholdt","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1586\/17474124.2014.881715","article-title":"Adverse events in Ibd: to stop or continue immune suppressant and biologic treatment","volume":"8","author":"McLean","year":"2014","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.cgh.2016.08.044","article-title":"Efficacy of vedolizumab induction and maintenance therapy in patients with ulcerative colitis, regardless of prior exposure to tumor necrosis factor antagonists","volume":"15","author":"Feagan","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izy269","article-title":"Cell trafficking interference in inflammatory bowel disease: therapeutic interventions based on basic pathogenesis concepts","volume":"25","author":"P\u00e9rez-Jeldres","year":"2019","journal-title":"Inflammation Bowel Dis"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjw176","article-title":"Long-term efficacy of vedolizumab for Crohn\u2019s disease","volume":"11","author":"Vermeire","year":"2016","journal-title":"J Crohn\u2019s Colitis"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1016\/j.cgh.2023.09.010","article-title":"Vedolizumab, adalimumab, and methotrexate combination therapy in crohn\u2019s disease (Explorer)","volume":"22","author":"Colombel","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.4161\/mabs.3.6.17815","article-title":"Discovery and mechanism of ustekinumab: A human monoclonal antibody targeting interleukin-12 and interleukin-23 for treatment of immune-mediated disorders","volume":"3","author":"Benson","year":"2011","journal-title":"MAbs"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1900750","article-title":"Ustekinumab as induction and maintenance therapy for ulcerative colitis","volume":"381","author":"Sands","year":"2019","journal-title":"N Engl J Med"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.2217\/cer-2017-0022","article-title":"Efficacy and safety of ustekinumab in the induction therapy of Tnf-A-refractory crohn\u2019s disease patients: A systematic review and meta-analysis","volume":"6","author":"Kawalec","year":"2017","journal-title":"J Comp Eff Res"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1177\/17562848211072412","article-title":"Effectiveness of ustekinumab in patients with refractory Crohn\u2019s disease: A multicentre real-life study in Italy","volume":"15","author":"Scribano","year":"2022","journal-title":"Therap Adv Gastroenterol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.14309\/ajg.0000000000002621","article-title":"Efficacy and safety of ustekinumab for ulcerative colitis through 4 years: final results of the unifi long-term maintenance study","volume":"119","author":"Afif","year":"2024","journal-title":"Am J Gastroenterol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v30.i35.3942","article-title":"Game changer: how janus kinase inhibitors are reshaping the landscape of ulcerative colitis management","volume":"30","author":"Caballero-Mateos","year":"2024","journal-title":"World J Gastroenterol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"s1","DOI":"10.1136\/gutjnl-2019-318484","article-title":"British society of gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults","volume":"68","author":"Lamb","year":"2019","journal-title":"Gut"},{"key":"B59","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1053\/j.gastro.2020.01.047","article-title":"Efficacy and safety of upadacitinib in a randomized trial of patients with Crohn\u2019s disease","volume":"158","author":"Sandborn","year":"2020","journal-title":"Gastroenterology"},{"key":"B60","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s40265-023-01840-5","article-title":"Safety of janus kinase inhibitors in inflammatory bowel diseases","volume":"83","author":"N\u00fa\u00f1ez","year":"2023","journal-title":"Drugs"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1080\/17474124.2023.2295496","article-title":"Risankizumab to treat moderately to severely active Crohn\u2019s disease in adults: an evaluation of trials and data","volume":"17","author":"Johnson","year":"2023","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1002\/cpt.893","article-title":"Anti-il-23 and anti-Il-17 biologic agents for the treatment of immune-mediated inflammatory conditions","volume":"103","author":"Frieder","year":"2018","journal-title":"Clin Pharmacol Ther"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2020.10.002","article-title":"Targeting B cells for inflammatory bowel disease treatment: back to the future","volume":"55","author":"Castro-Dopico","year":"2020","journal-title":"Curr Opin Pharmacol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_201812_16652","article-title":"Ppar-\u0393 with its anti-inflammatory and anti-fibrotic action could be an effective therapeutic target in Ibd","volume":"22","author":"Vetuschi","year":"2018","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izaa347.084","article-title":"Cadherin-11, an essential regulator of cell-cell adhesion upregulated in ibd patients, plays essential roles in promoting fibroblast activation and development of intestinal inflammation and fibrosis","volume":"27","author":"Li","year":"2021","journal-title":"Inflammatory Bowel Dis"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjac190.0695","article-title":"P565 comparison of the efficacy of adalimumab and ustekinumab for prevention of intestinal fibrosis in bio-naive Crohn\u2019s disease patients","volume":"17","author":"Biscanin","year":"2023","journal-title":"J Crohn\u2019s Colitis"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2023-329963","article-title":"Fibrosis in ibd: from pathogenesis to therapeutic targets","volume":"73","author":"Rieder","year":"2024","journal-title":"Gut"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.835005","article-title":"Intestinal fibrosis in inflammatory bowel disease and the prospects of mesenchymal stem cell therapy","volume":"13","author":"Wang","year":"2022","journal-title":"Front Immunol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2017.3016","article-title":"Triptolide exerts protective effects against fibrosis following ileocolonic anastomosis by mechanisms involving the Mir-16-1\/Hsp70 pathway in Il-10-deficient mice","volume":"40","author":"Hou","year":"2017","journal-title":"Int J Mol Med"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1097\/mib.0000000000001044","article-title":"Endoscopic stricturotomy with needle knife in the treatment of strictures from inflammatory bowel disease","volume":"23","author":"Lan","year":"2017","journal-title":"Inflammation Bowel Dis"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S210315","article-title":"Nanoparticle-mediated drug delivery systems for the treatment of Ibd: current perspectives","volume":"14","author":"Yang","year":"2019","journal-title":"Int J Nanomedicine"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2017-315494","article-title":"Cell-centred meta-analysis reveals baseline predictors of anti-tnf\u03b1 Non-response in biopsy and blood of patients with Ibd","volume":"68","author":"Gaujoux","year":"2019","journal-title":"Gut"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjab232.589","article-title":"P462 upfront infliximab dose intensification for secondary loss of response in ibd: similar efficacy to dose interval shortening with the added advantage of early clinical and pharmacokinetic predictors of response","volume":"16","author":"Srinivasan","year":"2022","journal-title":"J Crohn\u2019s Colitis"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01626","article-title":"Anti-donor immune responses elicited by allogeneic mesenchymal stem cells and their extracellular vesicles: are we still learning","volume":"8","author":"Lohan","year":"2017","journal-title":"Front Immunol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"784","DOI":"10.3390\/cells8080784","article-title":"Mesenchymal stem cell migration and tissue repair","volume":"8","author":"Fu","year":"2019","journal-title":"Cells"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1111\/j.1582-4934.2009.00857.x","article-title":"Mesenchymal stem cell-based therapy: A new paradigm in regenerative medicine","volume":"13","author":"Satija","year":"2009","journal-title":"J Cell Mol Med"},{"key":"B77","doi-asserted-by":"publisher","first-page":"6649","DOI":"10.1038\/s41598-024-57070-6","article-title":"Bone marrow-derived mesenchymal stem cells mitigate chronic colitis and enteric neuropathy via anti-inflammatory and anti-oxidative mechanisms","volume":"14","author":"Stavely","year":"2024","journal-title":"Sci Rep"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.2147\/jir.S402592","article-title":"Mesenchymal stem cells ameliorate dss-induced experimental colitis by modulating the gut microbiota and muc-1 pathway","volume":"16","author":"Wang","year":"2023","journal-title":"J Inflammation Res"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.7150\/thno.105876","article-title":"Targeted delivery of grem1 and Il-10 separately by mesenchymal stem cells effectively mitigates Setd2-deficient inflammatory bowel disease","volume":"15","author":"Aji","year":"2025","journal-title":"Theranostics"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1002\/stem.2923","article-title":"Human cartilage-derived progenitors resist terminal differentiation and require Cxcr4 activation to successfully bridge meniscus tissue tears","volume":"37","author":"Jayasuriya","year":"2019","journal-title":"Stem Cells"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/8106818","article-title":"Mesenchymal stem cells: characteristics, function, and application","volume":"2019","author":"Li","year":"2019","journal-title":"Stem Cells Int"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1126\/science.276.5309.71","article-title":"Marrow stromal cells as stem cells for nonhematopoietic tissues","volume":"276","author":"Prockop","year":"1997","journal-title":"Science"},{"key":"B83","doi-asserted-by":"publisher","first-page":"73","DOI":"10.4252\/wjsc.v8.i3.73","article-title":"Homing and migration of mesenchymal stromal cells: how to improve the efficacy of cell therapy","volume":"8","author":"De Becker","year":"2016","journal-title":"World J Stem Cells"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-019-03125-1","article-title":"Biological functions of mesenchymal stem cells and clinical implications","volume":"76","author":"Naji","year":"2019","journal-title":"Cell Mol Life Sci"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1002\/stem.2575","article-title":"Concise review: Msc-derived exosomes for cell-free therapy","volume":"35","author":"Phinney","year":"2017","journal-title":"Stem Cells"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1016\/j.jare.2023.12.006","article-title":"The nlrp3 molecule influences the therapeutic effects of mesenchymal stem cells through glut1-mediated energy metabolic reprogramming","volume":"65","author":"Chen","year":"2024","journal-title":"J Advanced Res"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0220756","article-title":"Tsg-6 in extracellular vesicles from canine mesenchymal stem\/stromal is a major factor in relieving Dss-induced colitis","volume":"15","author":"An","year":"2020","journal-title":"PLoS One"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1002\/stem.1191","article-title":"Human mesenchymal stem\/stromal cells cultured as spheroids are self-activated to produce prostaglandin E2 that directs stimulated macrophages into an anti-inflammatory phenotype","volume":"30","author":"Yl\u00f6stalo","year":"2012","journal-title":"Stem Cells"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-12-327353","article-title":"Anti-inflammatory protein Tsg-6 secreted by activated mscs attenuates zymosan-induced mouse peritonitis by decreasing Tlr2\/Nf-Kb signaling in resident macrophages","volume":"118","author":"Choi","year":"2011","journal-title":"Blood"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1016\/j.joca.2012.06.003","article-title":"Mesenchymal stem cells secrete factors that inhibit inflammatory processes in short-term osteoarthritic synovium and cartilage explant culture","volume":"20","author":"van Buul","year":"2012","journal-title":"Osteoarthritis Cartilage"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1186\/s40902-017-0106-4","article-title":"Angiogenesis in newly regenerated bone by secretomes of human mesenchymal stem cells","volume":"39","author":"Katagiri","year":"2017","journal-title":"Maxillofac Plast Reconstr Surg"},{"key":"B92","doi-asserted-by":"publisher","first-page":"3609","DOI":"10.1038\/s41598-022-07569-7","article-title":"Human infrapatellar fat pad mesenchymal stem cells show immunomodulatory exosomal signatures","volume":"12","author":"Kouroupis","year":"2022","journal-title":"Sci Rep"},{"key":"B93","doi-asserted-by":"publisher","first-page":"BSR20203573","DOI":"10.1042\/bsr20203573","article-title":"Exosomes derived from lps-stimulated human thymic mesenchymal stromal cells enhance inflammation via thrombospondin-1","volume":"41","author":"Li","year":"2021","journal-title":"Biosci Rep"},{"key":"B94","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s13287-025-04197-6","article-title":"Huc-mscs-derived exosomes alleviate non-alcoholic steatohepatitis by regulating macrophages polarization through Mir-24-3p\/Sting axis","volume":"16","author":"Jiang","year":"2025","journal-title":"Stem Cell Res Ther"},{"key":"B95","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13287-020-02068-w","article-title":"Microrna-27b shuttled by mesenchymal stem cell-derived exosomes prevents sepsis by targeting Jmjd3 and downregulating Nf-Kb signaling pathway","volume":"12","author":"Sun","year":"2021","journal-title":"Stem Cell Res Ther"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1002\/stem.2564","article-title":"Exosomal mir-146a contributes to the enhanced therapeutic efficacy of interleukin-1\u03b2-primed mesenchymal stem cells against sepsis","volume":"35","author":"Song","year":"2017","journal-title":"Stem Cells"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1007\/s13770-020-00324-x","article-title":"Exosomes from il-1\u03b2-primed mesenchymal stem cells inhibited Il-1\u03b2- and Tnf-A-mediated inflammatory responses in osteoarthritic Sw982 cells","volume":"18","author":"Kim","year":"2021","journal-title":"Tissue Eng Regener Med"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvz040","article-title":"Mesenchymal stromal cell-derived exosomes attenuate myocardial ischaemia-reperfusion injury through mir-182-regulated macrophage polarization","volume":"115","author":"Zhao","year":"2019","journal-title":"Cardiovasc Res"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtos.2023.03.002","article-title":"Micrornas of extracellular vesicles derived from mesenchymal stromal cells alleviate inflammation in dry eye disease by targeting the Irak1\/Tab2\/Nf-Kb pathway","volume":"28","author":"Wang","year":"2023","journal-title":"Ocul Surf"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtn.2023.102102","article-title":"Modulation of experimental acute lung injury by exosomal mir-7704 from mesenchymal stromal cells acts through M2 macrophage polarization","volume":"35","author":"Lin","year":"2024","journal-title":"Mol Ther Nucleic Acids"},{"key":"B101","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1186\/s12951-023-01997-x","article-title":"Mesenchymal stem cells, as glioma exosomal immunosuppressive signal multipliers, enhance mdscs immunosuppressive activity through the Mir-21\/Sp1\/Dnmt1 positive feedback loop","volume":"21","author":"Qiu","year":"2023","journal-title":"J Nanobiotechnology"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.14348\/molcells.2019.2283","article-title":"Attenuation of experimental autoimmune hepatitis in mice with bone mesenchymal stem cell-derived exosomes carrying microrna-223-3p","volume":"42","author":"Lu","year":"2019","journal-title":"Mol Cells"},{"key":"B103","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1186\/s12967-015-0642-6","article-title":"Lps-preconditioned mesenchymal stromal cells modify macrophage polarization for resolution of chronic inflammation via exosome-shuttled let-7b","volume":"13","author":"Ti","year":"2015","journal-title":"J Transl Med"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/6953963","article-title":"Hucmscs attenuate Ibd through releasing Mir148b-5p to inhibit the expression of 15-lox-1 in macrophages","volume":"2019","author":"Kang","year":"2019","journal-title":"Mediators Inflammation"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S355366","article-title":"Targeted therapy for inflammatory diseases with mesenchymal stem cells and their derived exosomes: from basic to clinics","volume":"17","author":"Wang","year":"2022","journal-title":"IJN"},{"key":"B106","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1167\/iovs.18-25617","article-title":"Exosomes derived from mesenchymal stem cells modulate Mir-126 to ameliorate hyperglycemia-induced retinal inflammation via targeting hmgb1","volume":"60","author":"Zhang","year":"2019","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2019.04.020","article-title":"Extracellular vesicles derived from bone marrow mesenchymal stem cells attenuate dextran sodium sulfate-induced ulcerative colitis by promoting M2 macrophage polarization","volume":"72","author":"Cao","year":"2019","journal-title":"Int Immunopharmacol"},{"key":"B108","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/s41419-020-02788-0","article-title":"Ifn-\u0393 Promoted exosomes from mesenchymal stem cells to attenuate colitis via Mir-125a and Mir-125b","volume":"11","author":"Yang","year":"2020","journal-title":"Cell Death Dis"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1016\/j.biochi.2020.02.011","article-title":"Exosomal Nrf2: from anti-oxidant and anti-inflammation response to wound healing and tissue regeneration in aged-related diseases","author":"Kahroba","year":"2020","journal-title":"Biochimie"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.22037\/ipa.v1i1.19968","article-title":"Exosomes, microvesicles as diagnosis, therapeutic and drug delivery tools","volume":"1","author":"Kazemi","year":"2018","journal-title":"Int Pharm Acta"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1039\/d1nr01314a","article-title":"Cell-free exosome-laden scaffolds for tissue repair","volume":"13","author":"Huang","year":"2021","journal-title":"Nanoscale"},{"key":"B112","doi-asserted-by":"publisher","first-page":"459","DOI":"10.3390\/biom14040459","article-title":"Applications of exosomal mirnas from mesenchymal stem cells as skin boosters","volume":"14","author":"Zheng","year":"2024","journal-title":"Biomolecules"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1102001","article-title":"Microrna-125b potentiates macrophage activation","volume":"187","author":"Chaudhuri","year":"2011","journal-title":"J Immunol"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1007\/s12015-024-10803-6","article-title":"Can mirnas in mscs-evs offer a potential treatment for hypoxic-ischemic encephalopathy","volume":"21","author":"Al-Ward","year":"2025","journal-title":"Stem Cell Rev Rep"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M112.414862","article-title":"Mir-155 regulates immune modulatory properties of mesenchymal stem cells by targeting tak1-binding protein 2","volume":"288","author":"Xu","year":"2013","journal-title":"J Biol Chem"},{"key":"B116","doi-asserted-by":"publisher","first-page":"588","DOI":"10.3390\/antiox12030588","article-title":"Bone marrow mesenchymal stem-cell-derived exosomes ameliorate deoxynivalenol-induced mice liver damage","volume":"12","author":"Meng","year":"2023","journal-title":"Antioxidants (Basel)"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1634\/stemcells.2006-0686","article-title":"Angiogenic effects of human multipotent stromal cell conditioned medium activate the Pi3k-Akt pathway in hypoxic endothelial cells to inhibit apoptosis, increase survival, and stimulate angiogenesis","volume":"25","author":"Hung","year":"2007","journal-title":"Stem Cells"},{"key":"B118","doi-asserted-by":"publisher","first-page":"805","DOI":"10.3390\/bioengineering9120805","article-title":"Hypothermic preservation of adipose-derived mesenchymal stromal cells as a viable solution for the storage and distribution of cell therapy products","volume":"9","author":"Branco","year":"2022","journal-title":"Bioengineering (Basel)"},{"key":"B119","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.3390\/biom14111353","article-title":"Mesenchymal stem cell-derived exosomes: emerging as a promising cell-free therapeutic strategy for autoimmune hepatitis","volume":"14","author":"Wu","year":"2024","journal-title":"Biomolecules"},{"key":"B120","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13287-018-0791-7","article-title":"Mesenchymal stem cell-derived extracellular vesicles: novel frontiers in regenerative medicine","volume":"9","author":"Keshtkar","year":"2018","journal-title":"Stem Cell Res Ther"},{"key":"B121","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41581-018-0023-5","article-title":"Immunoregulatory mechanisms of mesenchymal stem and stromal cells in inflammatory diseases","volume":"14","author":"Shi","year":"2018","journal-title":"Nat Rev Nephrol"},{"key":"B122","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1053\/j.gastro.2008.10.014","article-title":"Degeneration of the pericryptal myofibroblast sheath by proinflammatory cytokines in inflammatory bowel diseases","volume":"136","author":"Francoeur","year":"2009","journal-title":"Gastroenterology"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-005-1727-4","article-title":"Colonic subepithelial myofibroblasts in mucosal inflammation and repair: contribution of bone marrow-derived stem cells to the gut regenerative response","volume":"40","author":"Andoh","year":"2005","journal-title":"J Gastroenterol"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i48.18228","article-title":"Intravenous vs intraperitoneal mesenchymal stem cells administration: what is the best route for treating experimental colitis","volume":"20","author":"Gon\u00e7alves Fda","year":"2014","journal-title":"World J Gastroenterol"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v18.i10.1048","article-title":"Intravenous injection of mesenchymal stem cells is effective in treating liver fibrosis","volume":"18","author":"Zhao","year":"2012","journal-title":"World J Gastroenterol"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2006.12.029","article-title":"Nonmyeloablative stem cell therapy enhances microcirculation and tissue regeneration in murine inflammatory bowel disease","volume":"132","author":"Khalil","year":"2007","journal-title":"Gastroenterology"},{"key":"B127","doi-asserted-by":"publisher","first-page":"2624","DOI":"10.3390\/ijms20112624","article-title":"Enhanced homing of mesenchymal stem cells overexpressing fibroblast growth factor 21 to injury site in a mouse model of traumatic brain injury","volume":"20","author":"Shahror","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1039\/c9bm00242a","article-title":"In vivo migration of Fe3O4@Polydopamine nanoparticle-labeled mesenchymal stem cells to burn injury sites and their therapeutic effects in a rat model","volume":"7","author":"Li","year":"2019","journal-title":"Biomater Sci"},{"key":"B129","doi-asserted-by":"publisher","first-page":"17646","DOI":"10.1038\/s41598-019-54194-y","article-title":"Mechanism and therapeutic effect of umbilical cord mesenchymal stem cells in inflammatory bowel disease","volume":"9","author":"Pan","year":"2019","journal-title":"Sci Rep"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1007\/s10787-019-00683-5","article-title":"Human umbilical cord mesenchymal stem cells alleviate inflammatory bowel disease by inhibiting Erk phosphorylation in neutrophils","volume":"28","author":"Wang","year":"2020","journal-title":"Inflammopharmacology"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.112810","article-title":"Intestinal epithelial cell-derived exosomes package microrna-23a-3p alleviate gut damage after ischemia\/reperfusion via targeting Map4k4","volume":"149","author":"Yang","year":"2022","journal-title":"BioMed Pharmacother"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcis.2024.05.162","article-title":"Exosomes derived from mesenchymal stem cells containing berberine for ulcerative colitis therapy","volume":"671","author":"Deng","year":"2024","journal-title":"J Colloid Interface Sci"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.131273","article-title":"Exosomes from mesenchymal stromal cells reduce murine colonic inflammation via a macrophage-dependent mechanism","volume":"4","author":"Liu","year":"2020","journal-title":"JCI Insight"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjab001","article-title":"Impairment of tissue-resident mesenchymal stem cells in chronic ulcerative colitis and Crohn\u2019s disease","volume":"15","author":"Grim","year":"2021","journal-title":"J Crohns Colitis"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2014.11.042","article-title":"Gremlin 1 identifies a skeletal stem cell with bone, cartilage, and reticular stromal potential","volume":"160","author":"Worthley","year":"2015","journal-title":"Cell"},{"key":"B136","doi-asserted-by":"publisher","first-page":"26248905","DOI":"10.3390\/ijms23168905","article-title":"Mesenchymal (Stem) stromal cells based as new therapeutic alternative in inflammatory bowel disease: basic mechanisms, experimental and clinical evidence, and challenges","volume":"23","author":"Eiro","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B137","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s13287-019-1263-4","article-title":"Effect of ectopic high expression of transcription factor Oct4 on the \u201cStemness\u201d Characteristics of human bone marrow-derived mesenchymal stromal cells","volume":"10","author":"Guo","year":"2019","journal-title":"Stem Cell Res Ther"},{"key":"B138","doi-asserted-by":"publisher","first-page":"76","DOI":"10.21705\/mcbs.v4i2.100","article-title":"Isolation, characterization, proliferation and differentiation of synovial membrane-derived mesenchymal stem cells (Sm-Mscs) from osteoarthritis patients","volume":"4","author":"Marlina","year":"2020","journal-title":"Mol Cell Biomed Sci"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202300424","article-title":"Hippo pathway activation in aged mesenchymal stem cells contributes to the dysregulation of hepatic inflammation in aged mice","volume":"10","author":"Yang","year":"2023","journal-title":"Adv Sci (Weinh)"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1002\/stem.3014","article-title":"Low-dose pesticide mixture induces accelerated mesenchymal stem cell aging in vitro","volume":"37","author":"Leveque","year":"2019","journal-title":"Stem Cells"},{"key":"B141","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2023\/4245704","article-title":"Mesenchymal stem cell-derived exosomes: novel therapeutic approach for inflammatory bowel diseases","volume":"2023","author":"Tian","year":"2023","journal-title":"Stem Cells Int"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.749192","article-title":"Effects of mesenchymal stem cell-derived exosomes on autoimmune diseases","volume":"12","author":"Shen","year":"2021","journal-title":"Front Immunol"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"Covid-19: consider cytokine storm syndromes and immunosuppression","volume":"395","author":"Mehta","year":"2020","journal-title":"Lancet"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2014.10.035","article-title":"Modulation of the inflammatory response to chitosan through M2 macrophage polarization using pro-resolution mediators","volume":"37","author":"Vasconcelos","year":"2015","journal-title":"Biomaterials"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00886","article-title":"Rank ligand helps immunity to leishmania major by skewing M2-like into M1 macrophages","volume":"11","author":"Rigoni","year":"2020","journal-title":"Front Immunol"},{"key":"B146","doi-asserted-by":"publisher","first-page":"319","DOI":"10.3390\/biomedicines10020319","article-title":"Metformin inhibits ros production by human M2 macrophages via the activation of ampk","volume":"10","author":"Nassif","year":"2022","journal-title":"Biomedicines"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01777","article-title":"Alveolar macrophages in the resolution of inflammation, tissue repair, and tolerance to infection","volume":"9","author":"Allard","year":"2018","journal-title":"Front Immunol"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-019-0172-4","article-title":"Macrophages in intestinal inflammation and resolution: A potential therapeutic target in Ibd","volume":"16","author":"Na","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B149","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1016\/j.cell.2019.10.027","article-title":"Mucosal profiling of pediatric-onset colitis and Ibd reveals common pathogenics and therapeutic pathways","volume":"179","author":"Huang","year":"2019","journal-title":"Cell"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.108361","article-title":"Nox4 promotes mucosal barrier injury in inflammatory bowel disease by mediating macrophages M1 polarization through Ros","volume":"104","author":"Han","year":"2022","journal-title":"Int Immunopharmacol"},{"key":"B151","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1007\/s10565-024-09921-1","article-title":"Hucmsc-ex alleviates inflammatory bowel disease in mice by enhancing M2-type macrophage polarization via the Mettl3-Slc37a2-Ythdf1 axis","volume":"40","author":"Xu","year":"2024","journal-title":"Cell Biol Toxicol"},{"key":"B152","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2017\/5356760","article-title":"Exosomes derived from human umbilical cord mesenchymal stem cells relieve inflammatory bowel disease in mice","volume":"2017","author":"Mao","year":"2017","journal-title":"BioMed Res Int"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.00407","article-title":"Tsg-6: A multifunctional protein associated with inflammation","volume":"116","author":"Milner","year":"2003","journal-title":"J Cell Sci"},{"key":"B154","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1186\/s13287-021-02411-9","article-title":"Placental chorionic plate-derived mesenchymal stem cells ameliorate severe acute pancreatitis by regulating macrophage polarization via secreting Tsg-6","volume":"12","author":"Huang","year":"2021","journal-title":"Stem Cell Res Ther"},{"key":"B155","doi-asserted-by":"publisher","first-page":"5187","DOI":"10.1038\/s41598-017-04766-7","article-title":"Tsg-6 secreted by human adipose tissue-derived mesenchymal stem cells ameliorates dss-induced colitis by inducing M2 macrophage polarization in mice","volume":"7","author":"Song","year":"2017","journal-title":"Sci Rep"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1416121111","article-title":"Tsg-6 as a biomarker to predict efficacy of human mesenchymal stem\/progenitor cells (Hmscs) in modulating sterile inflammation in vivo","volume":"111","author":"Lee","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/1240301","article-title":".Ccr2 positive exosome released by mesenchymal stem cells suppresses macrophage functions and alleviates ischemia\/reperfusion-induced renal injury","volume":"2016","author":"Shen","year":"2016","journal-title":"Stem Cells Int."},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.Can-07-1286","article-title":"Targeting ccl2 with systemic delivery of neutralizing antibodies induces prostate cancer tumor regression in vivo","volume":"67","author":"Loberg","year":"2007","journal-title":"Cancer Res"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2003.10.009","article-title":"Ccl2 (Monocyte chemoattractant protein-1) and cancer","volume":"14","author":"Conti","year":"2004","journal-title":"Semin Cancer Biol"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M109.042671","article-title":"Ccl2 and interleukin-6 promote survival of human Cd11b+ Peripheral blood mononuclear cells and induce M2-type macrophage polarization","volume":"284","author":"Roca","year":"2009","journal-title":"J Biol Chem"},{"key":"B161","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1186\/s13287-019-1447-y","article-title":"Msc-secreted Tgf-B Regulates lipopolysaccharide-stimulated macrophage M2-like polarization via the Akt\/Foxo1 pathway","volume":"10","author":"Liu","year":"2019","journal-title":"Stem Cell Res Ther"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1021\/acs.nanolett.4c03418","article-title":"Blocking metallothionein-2 expression by copper-doped carbon dots induces cellular antioxidant system collapse for antitumor therapy","volume":"24","author":"Liu","year":"2024","journal-title":"Nano Lett"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjae110","article-title":"Mscs-exosomes can promote macrophage M2 polarization via exosomal mir-21-5p through mesenteric injection: A promising way to attenuate murine colitis","volume":"18","author":"Qian","year":"2024","journal-title":"J Crohns Colitis"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.14336\/ad.2023.0719-1","article-title":"Mesenchymal stem cell-derived exosomes promote recovery of the facial nerve injury through regulating macrophage M1 and M2 polarization by targeting the P38 Mapk\/Nf-Kb pathway","volume":"15","author":"Xue","year":"2024","journal-title":"Aging Dis"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1089\/scd.2013.0479","article-title":"Mesenchymal stem cells secrete immunologically active exosomes","volume":"23","author":"Zhang","year":"2014","journal-title":"Stem Cells Dev"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.1016\/j.cej.2024.154432","article-title":"Exosomes derived from 3d-cultured mscs alleviate knee osteoarthritis by promoting M2 macrophage polarization through mir-365a-5p and inhibiting Tlr2\/Myd88\/Nf-Kb pathway","volume":"497","author":"Yan","year":"2024","journal-title":"Chem Eng J"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2024.1384420","article-title":"Regulation of immune responses to infection through interaction between stem cell-derived exosomes and toll-like receptors mediated by microrna cargoes","volume":"14","author":"Moghaddam","year":"2024","journal-title":"Front Cell Infect Microbiol"},{"key":"B168","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1186\/s13287-022-03010-y","article-title":"Mesenchymal stem cell-derived exosomes protect against liver fibrosis via delivering Mir-148a to target Klf6\/Stat3 pathway in macrophages","volume":"13","author":"Tian","year":"2022","journal-title":"Stem Cell Res Ther"},{"key":"B169","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13287-020-1550-0","article-title":"Exosomes derived from human umbilical cord mesenchymal stem cells ameliorate Il-6-induced acute liver injury through Mir-455-3p","volume":"11","author":"Shao","year":"2020","journal-title":"Stem Cell Res Ther"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2024.1331218","article-title":"Exosomes derived from msc as drug system in osteoarthritis therapy","volume":"12","author":"Wen","year":"2024","journal-title":"Front Bioeng Biotechnol"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.1021\/acs.molpharmaceut.8b00237","article-title":"Modulating macrophage polarization through Ccr2 inhibition and multivalent engagement","volume":"15","author":"Deci","year":"2018","journal-title":"Mol Pharm"},{"key":"B172","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/1240301","article-title":"Ccr2 positive exosome released by mesenchymal stem cells suppresses macrophage functions and alleviates ischemia\/reperfusion-induced renal injury","volume":"2016","author":"Shen","year":"2016","journal-title":"Stem Cells Int"},{"key":"B173","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.3390\/pharmaceutics15051489","article-title":"Mesenchymal stromal cell exosomes mediate M2-like macrophage polarization through Cd73\/Ecto-5\u2019-nucleotidase activity","volume":"15","author":"Teo","year":"2023","journal-title":"Pharmaceutics"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjad212.0059","article-title":"Dop19 high dimensional profiling of Il-23-responsive cells revealed molecular signatures that predict response to anti-Il-23 therapy in patients with crohn\u2019s disease","volume":"18","author":"Cao","year":"2024","journal-title":"J Crohn\u2019s Colitis"},{"key":"B175","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.3390\/ijms21072263","article-title":"Hsp70\/Il-2 treated nk cells effectively cross the blood brain barrier and target tumor cells in a rat model of induced glioblastoma multiforme (Gbm)","volume":"21","author":"Sharifzad","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B176","doi-asserted-by":"publisher","first-page":"11162","DOI":"10.3390\/ijms231911162","article-title":"Lactobacillus rhamnosus cy12 enhances intestinal barrier function by regulating tight junction protein expression, oxidative stress, and inflammation response in lipopolysaccharide-induced caco-2 cells","volume":"23","author":"Zheng","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B177","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.3390\/ijms18091997","article-title":"Anti-nkg2d mab: A new treatment for Crohn\u2019s disease","volume":"18","author":"Vadstrup","year":"2017","journal-title":"Int J Mol Sci"},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izae020.090","article-title":"Unique monocyte expression signature in a Stxbp2 mutation causing infantile onset Veo-Ibd and Hlh","volume":"30","author":"Baccarella","year":"2024","journal-title":"Inflammatory Bowel Dis"},{"key":"B179","doi-asserted-by":"publisher","DOI":"10.1111\/sji.12751","article-title":"Human gingiva-derived mesenchymal stem cells alleviate inflammatory bowel disease via Il-10 signalling-dependent modulation of immune cells","volume":"90","author":"Lu","year":"2019","journal-title":"Scandinavian J Immunol"},{"key":"B180","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.952262","article-title":"Liver mesenchymal stem cells are superior inhibitors of nk cell functions through differences in their secretome compared to other mesenchymal stem cells","volume":"13","author":"Yigitbilek","year":"2022","journal-title":"Front Immunol"},{"key":"B181","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s13287-022-02777-4","article-title":"Mesenchymal stem cells and natural killer cells interaction mechanisms and potential clinical applications","volume":"13","author":"Abbasi","year":"2022","journal-title":"Stem Cell Res Ther"},{"key":"B182","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0107054","article-title":"Mhc-I molecules selectively inhibit cell-mediated cytotoxicity triggered by itam-coupled activating receptors and 2b4","volume":"9","author":"Corral-San Miguel","year":"2014","journal-title":"PLoS One"},{"key":"B183","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12943-019-0982-6","article-title":"Exosome-orchestrated hypoxic tumor microenvironment","volume":"18","author":"Meng","year":"2019","journal-title":"Mol Cancer"},{"key":"B184","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.Am2018-4736","article-title":"Abstract 4736: bone marrow microenvironment-induced mir-300 expression impairs natural killer cell proliferation and antitumor activity","volume":"78","author":"Trotta","year":"2018","journal-title":"Cancer Res"},{"key":"B185","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2015.00471","article-title":"How neutrophils shape adaptive immune responses","volume":"6","author":"Leliefeld","year":"2015","journal-title":"Front Immunol"},{"key":"B186","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.autrev.2013.06.004","article-title":"Innate and adaptive immunity in inflammatory bowel disease","volume":"13","author":"Geremia","year":"2014","journal-title":"Autoimmun Rev"},{"key":"B187","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02538","article-title":"Mesenchymal stromal cell-derived extracellular vesicles attenuate dendritic cell maturation and function","volume":"9","author":"Reis","year":"2018","journal-title":"Front Immunol"},{"key":"B188","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.29601","article-title":"Effect of mesenchymal stem cell-derived exosomes on the induction of mouse tolerogenic dendritic cells","volume":"235","author":"Shahir","year":"2020","journal-title":"J Cell Physiol"},{"key":"B189","doi-asserted-by":"publisher","DOI":"10.1016\/j.stemcr.2017.04.008","article-title":"Msc-derived extracellular vesicles attenuate immune responses in two autoimmune murine models: type 1 diabetes and uveoretinitis","volume":"8","author":"Shigemoto-Kuroda","year":"2017","journal-title":"Stem Cell Rep"},{"key":"B190","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.114593","article-title":"Mesenchymal stem cell-derived exosomal microrna-367-3p alleviates experimental autoimmune encephalomyelitis via inhibition of microglial ferroptosis by targeting Ezh2","volume":"162","author":"Fan","year":"2023","journal-title":"BioMed Pharmacother"},{"key":"B191","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3748\/wjg.v20.i1.6","article-title":"Immunopathology of inflammatory bowel disease","volume":"20","author":"Wallace","year":"2014","journal-title":"World J Gastroenterol"},{"key":"B192","doi-asserted-by":"publisher","DOI":"10.1155\/2023\/4245704","article-title":"Mesenchymal stem cell-derived exosomes: novel therapeutic approach for inflammatory bowel diseases","volume":"2023","author":"Tian","year":"2023","journal-title":"Stem Cells Int"},{"key":"B193","doi-asserted-by":"publisher","first-page":"4378","DOI":"10.3390\/ijms25084378","article-title":"Molecular mechanisms responsible for the therapeutic potential of mesenchymal stem cell-derived exosomes in the treatment of lung fibrosis","volume":"25","author":"Harrell","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B194","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.2010.00923.x","article-title":"The Pd-1 pathway in tolerance and autoimmunity","volume":"236","author":"Francisco","year":"2010","journal-title":"Immunol Rev"},{"key":"B195","doi-asserted-by":"publisher","DOI":"10.1002\/stem.2509","article-title":"Mesenchymal stromal cell secretion of programmed death-1 ligands regulates T cell mediated immunosuppression","volume":"35","author":"Davies","year":"2017","journal-title":"Stem Cells"},{"key":"B196","doi-asserted-by":"publisher","DOI":"10.1038\/labinvest.2009.66","article-title":"Tumor suppressor Foxo3 participates in the regulation of intestinal inflammation","volume":"89","author":"Snoeks","year":"2009","journal-title":"Lab Invest"},{"key":"B197","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.3390\/biomedicines9111507","article-title":"Improving the efficacy of mesenchymal stem\/stromal-based therapy for treatment of inflammatory bowel diseases","volume":"9","author":"Lopez-Santalla","year":"2021","journal-title":"Biomedicines"},{"key":"B198","doi-asserted-by":"publisher","DOI":"10.1002\/stem.3190","article-title":"N-glycosylation controls inflammatory licensing-triggered Pd-L1 upregulation in human mesenchymal stromal cells","volume":"38","author":"Strauch","year":"2020","journal-title":"Stem Cells"},{"key":"B199","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20090847","article-title":"Pd-L1 regulates the development, maintenance, and function of induced regulatory T cells","volume":"206","author":"Francisco","year":"2009","journal-title":"J Exp Med"},{"key":"B200","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.830606","article-title":"The interaction between the soluble programmed death ligand-1 (Spd-L1) and Pd-1(+) regulator B cells mediates immunosuppression in triple-negative breast cancer","volume":"13","author":"Li","year":"2022","journal-title":"Front Immunol"},{"key":"B201","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.imlet.2012.06.001","article-title":"Microvesicles derived from mesenchymal stem cells: potent organelles for induction of tolerogenic signaling","volume":"147","author":"Mokarizadeh","year":"2012","journal-title":"Immunol Lett"},{"key":"B202","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.827921","article-title":"Biological characteristics and clinical significance of soluble Pd-1\/Pd-L1 and exosomal Pd-L1 in cancer","volume":"13","author":"Niu","year":"2022","journal-title":"Front Immunol"},{"key":"B203","doi-asserted-by":"publisher","first-page":"A315","DOI":"10.1136\/jitc-2021-SITC2021.291","article-title":"291 dual-specific antibodies blocking both Pd-L1 and Pd-L2 engagement of Pd-1 restore anti-tumor immunity","volume":"9","author":"Couillault","year":"2021","journal-title":"J ImmunoTherapy Cancer"},{"key":"B204","doi-asserted-by":"publisher","DOI":"10.1002\/stem.2393","article-title":"Cancer stem cell-secreted macrophage migration inhibitory factor stimulates myeloid derived suppressor cell function and facilitates glioblastoma immune evasion","volume":"34","author":"Otvos","year":"2016","journal-title":"Stem Cells"},{"key":"B205","doi-asserted-by":"publisher","DOI":"10.1002\/stem.2280","article-title":"Adenosinergic immunosuppression by human mesenchymal stromal cells requires co-operation with T cells","volume":"34","author":"Kerkel\u00e4","year":"2016","journal-title":"Stem Cells"},{"key":"B206","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1007654108","article-title":"The interaction of human natural killer cells with either unpolarized or polarized macrophages results in different functional outcomes","volume":"107","author":"Bellora","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B207","doi-asserted-by":"publisher","DOI":"10.1007\/s12026-016-8798-6","article-title":"Immunomodulatory effects of mesenchymal stromal cells-derived exosome","volume":"64","author":"Chen","year":"2016","journal-title":"Immunol Res"},{"key":"B208","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-024-01858-1","article-title":"Il-12 induces a B cell-intrinsic Il-12\/Ifn\u03b3 Feed-forward loop promoting extrafollicular B cell responses","volume":"25","author":"Elsner","year":"2024","journal-title":"Nat Immunol"},{"key":"B209","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1186\/s12951-023-02087-8","article-title":"Exosomes derived from lps-preconditioned bone marrow-derived msc modulate macrophage plasticity to promote allograft survival via the Nf-Kb\/Nlrp3 signaling pathway","volume":"21","author":"Zhang","year":"2023","journal-title":"J Nanobiotechnology"},{"key":"B210","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/8813558","article-title":"The function and role of the Th17\/Treg cell balance in inflammatory bowel disease","volume":"2020","author":"Yan","year":"2020","journal-title":"J Immunol Res"},{"key":"B211","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00406","article-title":"Fresh evidence for platelets as neuronal and innate immune cells: their role in the activation, differentiation, and deactivation of Th1, Th17, and Tregs during tissue inflammation","volume":"9","author":"Ponomarev","year":"2018","journal-title":"Front Immunol"},{"key":"B212","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1186\/s13287-021-02404-8","article-title":"A novel therapeutic approach for inflammatory bowel disease by exosomes derived from human umbilical cord mesenchymal stem cells to repair intestinal barrier via Tsg-6","volume":"12","author":"Yang","year":"2021","journal-title":"Stem Cell Res Ther"},{"key":"B213","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s13287-023-03263-1","article-title":"Perinatal tissue-derived exosomes ameliorate colitis in mice by regulating the Foxp3\u2009+\u2009Treg cells and gut microbiota","volume":"14","author":"Yan","year":"2023","journal-title":"Stem Cell Res Ther"},{"key":"B214","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1075813","article-title":"The emerging role of regulatory cell-based therapy in autoimmune disease","volume":"13","author":"Ghobadinezhad","year":"2022","journal-title":"Front Immunol"},{"key":"B215","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-020711-074942","article-title":"Neutrophil function: from mechanisms to disease","volume":"30","author":"Amulic","year":"2012","journal-title":"Annu Rev Immunol"},{"key":"B216","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-01680-y","article-title":"Ulcerative colitis is characterized by a plasmablast-skewed humoral response associated with disease activity","volume":"28","author":"Uzzan","year":"2022","journal-title":"Nat Med"},{"key":"B217","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20220538","article-title":"Remodeling of colon plasma cell repertoire within ulcerative colitis patients","volume":"220","author":"Scheid","year":"2023","journal-title":"J Exp Med"},{"key":"B218","doi-asserted-by":"publisher","first-page":"e18344","DOI":"10.1111\/jcmm.18344","article-title":"Single cell sequencing data identify distinct B cell and fibroblast populations in stricturing Crohn\u2019s disease","volume":"28","author":"Humphreys","year":"2024","journal-title":"J Cell Mol Med"},{"key":"B219","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.cn112137-20200215-00298","article-title":"Association of breg cells and treg cells with the clinical effects of infliximab in the treatment of chinese patients with crohn\u2019s disease","volume":"100","author":"Lin","year":"2020","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"B220","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjw074","article-title":"Ulcerative colitis is characterized by a decrease in regulatory B cells","volume":"10","author":"Wang","year":"2016","journal-title":"J Crohns Colitis"},{"key":"B221","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s13287-016-0376-2","article-title":"Human umbilical cord-derived mesenchymal stem cells protect against experimental colitis via Cd5(+) B regulatory cells","volume":"7","author":"Chao","year":"2016","journal-title":"Stem Cell Res Ther"},{"key":"B222","doi-asserted-by":"publisher","DOI":"10.7150\/thno.32260","article-title":"Human mesenchymal stem cell-treated regulatory Cd23(+)Cd43(+) B cells alleviate intestinal inflammation","volume":"9","author":"Chen","year":"2019","journal-title":"Theranostics"},{"key":"B223","doi-asserted-by":"publisher","DOI":"10.1159\/000430338","article-title":"Induction of regulatory B-cells by mesenchymal stem cells is affected by Sdf-1\u03b1-Cxcr7","volume":"37","author":"Qin","year":"2015","journal-title":"Cell Physiol Biochem"},{"key":"B224","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2019.04.013","article-title":"The neutrophil life cycle","volume":"40","author":"Hidalgo","year":"2019","journal-title":"Trends Immunol"},{"key":"B225","doi-asserted-by":"publisher","DOI":"10.1042\/bst20190629","article-title":"The double-edged role of neutrophil extracellular traps in inflammation","volume":"47","author":"Euler","year":"2019","journal-title":"Biochem Soc Trans"},{"key":"B226","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1007\/s12016-020-08804-7","article-title":"A review of neutrophil extracellular traps (Nets) in disease: potential anti-nets therapeutics","volume":"61","author":"Mutua","year":"2021","journal-title":"Clin Rev Allergy Immunol"},{"key":"B227","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-023-00871-3","article-title":"Neutrophils: from ibd to the gut microbiota","volume":"21","author":"Danne","year":"2024","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B228","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2021.1968257","article-title":"Microbiota metabolite butyrate constrains neutrophil functions and ameliorates mucosal inflammation in inflammatory bowel disease","volume":"13","author":"Li","year":"2021","journal-title":"Gut Microbes"},{"key":"B229","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2021.04.004","article-title":"Mdsc: markers, development, states, and unaddressed complexity","volume":"54","author":"Hegde","year":"2021","journal-title":"Immunity"},{"key":"B230","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1021612","article-title":"Myeloid-derived suppressor cell: A crucial player in autoimmune diseases","volume":"13","author":"Xu","year":"2022","journal-title":"Front Immunol"},{"key":"B231","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1053\/j.gastro.2008.06.032","article-title":"Myeloid-derived suppressor cells in inflammatory bowel disease: A new immunoregulatory pathway","volume":"135","author":"Haile","year":"2008","journal-title":"Gastroenterology"},{"key":"B232","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2006.05.015","article-title":"Autoimmune-mediated intestinal inflammation-impact and regulation of antigen-specific Cd8+ T cells","volume":"131","author":"Westendorf","year":"2006","journal-title":"Gastroenterology"},{"key":"B233","doi-asserted-by":"publisher","DOI":"10.5966\/sctm.2015-0367","article-title":"Umbilical cord-derived mesenchymal stem cell-derived exosomal micrornas suppress myofibroblast differentiation by inhibiting the transforming growth factor-B\/Smad2 pathway during wound healing","volume":"5","author":"Fang","year":"2016","journal-title":"Stem Cells Transl Med"},{"key":"B234","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1900692","article-title":"Exosomes produced by mesenchymal stem cells drive differentiation of myeloid cells into immunosuppressive M2-polarized macrophages in breast cancer","volume":"203","author":"Biswas","year":"2019","journal-title":"J Immunol"},{"key":"B235","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-13-0278","article-title":"Downregulation of hematopoietic muc1 during experimental colitis increases tumor-promoting myeloid-derived suppressor cells","volume":"19","author":"Poh","year":"2013","journal-title":"Clin Cancer Res"},{"key":"B236","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s12974-022-02445-7","article-title":"Extracellular vesicles derived from mesenchymal stem cells alleviate neuroinflammation and mechanical allodynia in interstitial cystitis rats by inhibiting Nlrp3 inflammasome activation","volume":"19","author":"Zhang","year":"2022","journal-title":"J Neuroinflamm"},{"key":"B237","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/9847579","article-title":"Effects of mesenchymal stem cell coculture on human lung small airway epithelial cells","volume":"2020","author":"Schmelzer","year":"2020","journal-title":"BioMed Res Int"},{"key":"B238","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2011.04374.x","article-title":"Dextran sulphate sodium increases splenic Gr1(+)Cd11b(+) cells which accelerate recovery from colitis following intravenous transplantation","volume":"164","author":"Zhang","year":"2011","journal-title":"Clin Exp Immunol"},{"key":"B239","doi-asserted-by":"publisher","DOI":"10.1080\/08916934.2017.1283405","article-title":"Aberrant function of myeloid-derived suppressor cells (Mdscs) in experimental colitis and in inflammatory bowel disease (Ibd) immune responses","volume":"50","author":"Kontaki","year":"2017","journal-title":"Autoimmunity"},{"key":"B240","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2015.08.004","article-title":"The decoy substrate of a pathogen effector and a pseudokinase specify pathogen-induced modified-self recognition and immunity in plants","volume":"18","author":"Wang","year":"2015","journal-title":"Cell Host Microbe"},{"key":"B241","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00575","article-title":"Intestinal flora and disease mutually shape the regional immune system in the intestinal tract","volume":"11","author":"Zhou","year":"2020","journal-title":"Front Immunol"},{"key":"B242","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2015.01.002","article-title":"Disease-specific alterations in the enteric virome in inflammatory bowel disease","volume":"160","author":"Norman","year":"2015","journal-title":"Cell"},{"key":"B243","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjad212.1371","article-title":"P1241 distinct gut microbiota in Crohn\u2019s disease between inflammatory B1 and stricturing B2 phenotype","volume":"18","author":"Zhang","year":"2024","journal-title":"J Crohn\u2019s Colitis"},{"key":"B244","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1136\/gutjnl-2015-310746","article-title":"Fungal microbiota dysbiosis in ibd","volume":"66","author":"Sokol","year":"2017","journal-title":"Gut"},{"key":"B245","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjz203.970","article-title":"P842 analysis of fungal microbiota dysbiosis in inflammatory bowel disease","volume":"14","author":"Zeng","year":"2020","journal-title":"J Crohn\u2019s Colitis"},{"key":"B246","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2017.88","article-title":"Gut microbiota and ibd: causation or correlation","volume":"14","author":"Ni","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B247","doi-asserted-by":"publisher","DOI":"10.1002\/sctm.17-0305","article-title":"Mesenchymal stem cells (Msc) derived from induced pluripotent stem cells (Ipsc) equivalent to adipose-derived msc in promoting intestinal healing and microbiome normalization in mouse inflammatory bowel disease model","volume":"7","author":"Soontararak","year":"2018","journal-title":"Stem Cells Transl Med"},{"key":"B248","doi-asserted-by":"publisher","first-page":"e31","DOI":"10.1186\/s40169-019-0251-8","article-title":"Mesenchymal stem cell\u2013gut microbiota interaction in the repair of inflammatory bowel disease: an enhanced therapeutic effect","volume":"8","author":"Ocansey","year":"2019","journal-title":"Clin Trans Med"},{"key":"B249","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cellimm.2016.12.005","article-title":"Toll-like receptors as a key regulator of mesenchymal stem cell function: an up-to-date review","volume":"315","author":"Shirjang","year":"2017","journal-title":"Cell Immunol"},{"key":"B250","doi-asserted-by":"publisher","DOI":"10.1126\/science.1179721","article-title":"Metabolic syndrome and altered gut microbiota in mice lacking toll-like receptor 5","volume":"328","author":"Vijay-Kumar","year":"2010","journal-title":"Science"},{"key":"B251","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0106903","article-title":"Mesenchymal stem cells augment the anti-bacterial activity of neutrophil granulocytes","volume":"9","author":"Brandau","year":"2014","journal-title":"PLoS One"},{"key":"B252","doi-asserted-by":"publisher","DOI":"10.1038\/nm.1905","article-title":"Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production","volume":"15","author":"N\u00e9meth","year":"2009","journal-title":"Nat Med"},{"key":"B253","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2011-201176","article-title":"Mesenchymal stem cells enhance survival and bacterial clearance in murine escherichia coli pneumonia","volume":"67","author":"Gupta","year":"2012","journal-title":"Thorax"},{"key":"B254","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01787","article-title":"Mucosal mesenchymal cells: secondary barrier and peripheral educator for the gut immune system","volume":"8","author":"Kurashima","year":"2017","journal-title":"Front Immunol"},{"key":"B255","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/s13287-017-0670-7","article-title":"Microbiota regulates bone marrow mesenchymal stem cell lineage differentiation and immunomodulation","volume":"8","author":"Xiao","year":"2017","journal-title":"Stem Cell Res Ther"},{"key":"B256","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-021-00667-y","article-title":"Microbiota-derived lactate promotes hematopoiesis and erythropoiesis by inducing stem cell factor production from leptin receptor+ Niche cells","volume":"53","author":"Lee","year":"2021","journal-title":"Exp Mol Med"},{"key":"B257","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjad212.0305","article-title":"P175 hucmsc-exo ameliorate experimental colitis via modulating gut microbiota and metabolites","volume":"18","author":"Wang","year":"2024","journal-title":"J Crohn\u2019s Colitis"},{"key":"B258","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2020.4679","article-title":"Extracellular vesicles derived from human placental mesenchymal stem cells alleviate experimental colitis in mice by inhibiting inflammation and oxidative stress","volume":"46","author":"Duan","year":"2020","journal-title":"Int J Mol Med"},{"key":"B259","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.113","article-title":"Hucmsc-exosomes carrying mir-326 inhibit neddylation to relieve inflammatory bowel disease in mice","volume":"10","author":"Wang","year":"2020","journal-title":"Clin Transl Med"},{"key":"B260","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S402179","article-title":"Hucmsc-exo promote mucosal healing in experimental colitis by accelerating intestinal stem cells and epithelium regeneration via wnt signaling pathway","volume":"18","author":"Liang","year":"2023","journal-title":"IJN"},{"key":"B261","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2020.01.020","article-title":"Dual-functionalized mscs that express Cx3cr1 and Il-25 exhibit enhanced therapeutic effects on inflammatory bowel disease","volume":"28","author":"Fu","year":"2020","journal-title":"Mol Ther"},{"key":"B262","doi-asserted-by":"publisher","first-page":"11269","DOI":"10.3390\/ijms222011269","article-title":"Hif-overexpression and pro-inflammatory priming in human mesenchymal stromal cells improves the healing properties of extracellular vesicles in experimental Crohn\u2019s disease","volume":"22","author":"G\u00f3mez-Ferrer","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B263","doi-asserted-by":"publisher","first-page":"1790 p","DOI":"10.3390\/ijms22041790","article-title":"Hgf and Tsg-6 released by mesenchymal stem cells attenuate colon radiation-induced fibrosis","volume":"22","author":"Usunier","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B264","doi-asserted-by":"publisher","DOI":"10.1080\/08977194.2019.1652399","article-title":"Effects of hepatocyte growth factor gene-transfected mesenchymal stem cells on dimethylnitrosamine-induced liver fibrosis in rats","volume":"37","author":"Moon","year":"2019","journal-title":"Growth Factors"},{"key":"B265","doi-asserted-by":"publisher","DOI":"10.1038\/srep08713","article-title":"The anti-fibrotic effects of mesenchymal stem cells on irradiated lungs via stimulating endogenous secretion of Hgf and Pge2","volume":"5","author":"Dong","year":"2015","journal-title":"Sci Rep"},{"key":"B266","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.3390\/cells11071188","article-title":"Specific nlrp3 inflammasome assembling and regulation in neutrophils: relevance in inflammatory and infectious diseases","volume":"11","author":"Paget","year":"2022","journal-title":"Cells"},{"key":"B267","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2221007120","article-title":"Il-11 induces Nlrp3 inflammasome activation in monocytes and inflammatory cell migration to the central nervous system","volume":"120","author":"Seyedsadr","year":"2023","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B268","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-081022-021207","article-title":"Structural mechanisms of nlrp3 inflammasome assembly and activation","volume":"41","author":"Fu","year":"2023","journal-title":"Annu Rev Immunol"},{"key":"B269","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00276","article-title":"Nlrp3 inflammasome and inflammatory bowel disease","volume":"10","author":"Zhen","year":"2019","journal-title":"Front Immunol"},{"key":"B270","doi-asserted-by":"publisher","first-page":"2820","DOI":"10.1038\/s41598-018-20686-6","article-title":"Mesenchymal stromal cells inhibit nlrp3 inflammasome activation in a model of coxsackievirus B3-induced inflammatory cardiomyopathy","volume":"8","author":"Miteva","year":"2018","journal-title":"Sci Rep"},{"key":"B271","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.202006194","article-title":"The Nlrp3\u2013inflammasome as a sensor of organelle dysfunction","volume":"219","author":"Seoane","year":"2020","journal-title":"J Cell Biol"},{"key":"B272","doi-asserted-by":"publisher","DOI":"10.4161\/auto.28374","article-title":"Small molecule-driven mitophagy-mediated Nlrp3 inflammasome inhibition is responsible for the prevention of colitis-associated cancer","volume":"10","author":"Guo","year":"2014","journal-title":"Autophagy"},{"key":"B273","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.cell.2018.11.035","article-title":"Recirculating intestinal iga-producing cells regulate neuroinflammation via il-10","volume":"176","author":"Rojas","year":"2019","journal-title":"Cell"},{"key":"B274","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.3390\/cells9081808","article-title":"The nlrp3 inflammasome: metabolic regulation and contribution to inflammaging","volume":"9","author":"Meyers","year":"2020","journal-title":"Cells"},{"key":"B275","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2022.11.014","article-title":"Intranasally administered human msc-derived extracellular vesicles inhibit Nlrp3-P38\/Mapk signaling after tbi and prevent chronic brain dysfunction","volume":"108","author":"Kodali","year":"2023","journal-title":"Brain Behavior Immun"},{"key":"B276","doi-asserted-by":"publisher","DOI":"10.1002\/stem.1608","article-title":"Mesenchymal stem\/stromal cells inhibit the Nlrp3 inflammasome by decreasing mitochondrial reactive oxygen species","volume":"32","author":"Oh","year":"2014","journal-title":"Stem Cells"},{"key":"B277","doi-asserted-by":"publisher","DOI":"10.5483\/BMBRep.2020.53.6.065","article-title":"The activation of nlrp3 inflammasome potentiates the immunomodulatory abilities of mesenchymal stem cells in a murine colitis model","volume":"53","author":"Ahn","year":"2020","journal-title":"BMB Rep"},{"key":"B278","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1002\/iub.2759","article-title":"Mesenchymal stem cells (Mscs) and msc-derived exosomes in animal models of central nervous system diseases: targeting the Nlrp3 inflammasome","volume":"75","author":"Nazari","year":"2023","journal-title":"IUBMB Life"},{"key":"B279","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M506047200","article-title":"The muc1 sea module is a self-cleaving domain","volume":"280","author":"Levitin","year":"2005","journal-title":"J Biol Chem"},{"key":"B280","doi-asserted-by":"publisher","DOI":"10.1097\/MPA.0b013e3181bd6501","article-title":"Inflammation driven by overexpression of the hypoglycosylated abnormal mucin 1 (Muc1) links inflammatory bowel disease and pancreatitis","volume":"39","author":"Kadayakkara","year":"2010","journal-title":"Pancreas"},{"key":"B281","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22126567","article-title":"Muc1: structure, function, and clinic application in epithelial cancers","volume":"22","author":"Chen","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B282","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.10261","article-title":"Synergistic stimulation of muc1 expression in normal breast epithelia and breast cancer cells by interferon-gamma and tumor necrosis factor-alpha","volume":"86","author":"Lagow","year":"2002","journal-title":"J Cell Biochem"},{"key":"B283","doi-asserted-by":"publisher","DOI":"10.1080\/00016480310001268","article-title":"Tumor necrosis factor increases Muc1 Mrna in cultured human nasal epithelial cells","volume":"123","author":"Shirasaki","year":"2003","journal-title":"Acta Otolaryngol"},{"key":"B284","article-title":"Mucin-1 expression and localization in epithelial cells shows characteristic and distinct patterns in inflammatory bowel diseases and colorectal cancer","volume":"12","author":"Khemiri","year":"2019","journal-title":"Int J Clin Exp Pathol."},{"key":"B285","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.Can-05-2474","article-title":"Muc1 oncoprotein blocks glycogen synthase kinase 3beta-mediated phosphorylation and degradation of beta-catenin","volume":"65","author":"Huang","year":"2005","journal-title":"Cancer Res"},{"key":"B286","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.179.2.735","article-title":"Cutting edge: transgenic expression of human muc1 in Il-10-\/- mice accelerates inflammatory bowel disease and progression to colon cancer","volume":"179","author":"Beatty","year":"2007","journal-title":"J Immunol"},{"key":"B287","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/s41419-021-03559-1","article-title":"The emerging role of ferroptosis in intestinal disease","volume":"12","author":"Xu","year":"2021","journal-title":"Cell Death Dis"},{"key":"B288","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/2405943","article-title":"Mucin 1 inhibits ferroptosis and sensitizes vitamin E to alleviate sepsis-induced acute lung injury through Gsk3\u03b2\/Keap1-Nrf2-gpx4 pathway","volume":"2022","author":"Wang","year":"2022","journal-title":"Oxid Med Cell Longev"},{"key":"B289","doi-asserted-by":"publisher","first-page":"3331","DOI":"10.4081\/ejh.2021.3331","article-title":"Mucin1 relieves acute lung injury by inhibiting inflammation and oxidative stress","volume":"65","author":"Ye","year":"2021","journal-title":"Eur J Histochem"},{"key":"B290","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00422.2010","article-title":"Importance and regulation of the colonic mucus barrier in a mouse model of colitis","volume":"300","author":"Petersson","year":"2011","journal-title":"Am J Physiology-Gastrointestinal Liver Physiol"},{"key":"B291","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0087238","article-title":"Allo-reactivity of mesenchymal stem cells in rhesus macaques is dose and haplotype dependent and limits durable cell engraftment in vivo","volume":"9","author":"Isakova","year":"2014","journal-title":"PLoS One"},{"key":"B292","doi-asserted-by":"publisher","DOI":"10.1097\/mib.0000000000000441","article-title":"Human placenta-derived cells (Pda-001) for the treatment of moderate-to-severe crohn\u2019s disease: A phase 1b\/2a study","volume":"21","author":"Melmed","year":"2015","journal-title":"Inflammation Bowel Dis"},{"key":"B293","doi-asserted-by":"publisher","DOI":"10.5009\/gnl17035","article-title":"Umbilical cord mesenchymal stem cell treatment for crohn\u2019s disease: A randomized controlled clinical trial","volume":"12","author":"Zhang","year":"2018","journal-title":"Gut Liver"},{"key":"B294","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s13578-020-00427-x","article-title":"Extracellular vesicles derived from different sources of mesenchymal stem cells: therapeutic effects and translational potential","volume":"10","author":"Cai","year":"2020","journal-title":"Cell Biosci"},{"key":"B295","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjad212.0287","article-title":"P157 differentiation of tonsil-derived mesenchymal stem cells to intestinal stem cells-like cells for cell therapy of inflammatory bowel disease","volume":"18","author":"Song","year":"2024","journal-title":"J Crohn\u2019s Colitis"},{"key":"B296","doi-asserted-by":"publisher","DOI":"10.2174\/0126673878299775240719061653","article-title":"Current advancements on oral protein and peptide drug delivery approaches to bioavailability: extensive review on patents","volume":"18","author":"Parida","year":"2024","journal-title":"Recent Adv Drug Delivery Formul"},{"key":"B297","doi-asserted-by":"publisher","first-page":"2811","DOI":"10.3390\/foods13172811","article-title":"Exosomal delivery enhances the antiproliferative effects of acid-hydrolyzed apiaceae spice extracts in breast cancer cells","volume":"13","author":"Scott","year":"2024","journal-title":"Foods"},{"key":"B298","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202306482","article-title":"Selective uptake into inflamed human intestinal tissue and immune cell targeting by wormlike polymer micelles","volume":"20","author":"Gardey","year":"2024","journal-title":"Small"},{"key":"B299","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13287-023-03295-7","article-title":"Research progress of engineered mesenchymal stem cells and their derived exosomes and their application in autoimmune\/inflammatory diseases","volume":"14","author":"Zhu","year":"2023","journal-title":"Stem Cell Res Ther"},{"key":"B300","doi-asserted-by":"publisher","DOI":"10.1039\/d0bm01164a","article-title":"Recent advances in mesenchymal stem cell membrane-coated nanoparticles for enhanced drug delivery","volume":"9","author":"Wang","year":"2021","journal-title":"Biomater Sci"},{"key":"B301","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202303349","article-title":"Bioadhesive microcarriers encapsulated with il-27 high expressive msc extracellular vesicles for inflammatory bowel disease treatment","volume":"10","author":"Nie","year":"2023","journal-title":"Adv Sci (Weinh)"},{"key":"B302","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.176.5.2864","article-title":"The immunogenicity and immunomodulatory function of osteogenic cells differentiated from mesenchymal stem cells","volume":"176","author":"Liu","year":"2006","journal-title":"J Immunol"},{"key":"B303","doi-asserted-by":"publisher","DOI":"10.1093\/gastro\/goac075","article-title":"Evaluating the safety and efficacy of mesenchymal stem cell-derived exosomes for treatment of refractory perianal fistula in Ibd patients: clinical trial phase I","volume":"10","author":"Nazari","year":"2022","journal-title":"Gastroenterol Rep (Oxf)"},{"key":"B304","doi-asserted-by":"publisher","first-page":"e12004","DOI":"10.1002\/jev2.12004","article-title":"Covid-19 therapy with mesenchymal stromal cells (Msc) and convalescent plasma must consider exosome involvement: do the exosomes in convalescent plasma antagonize the weak immune antibodies","volume":"10","author":"Askenase","year":"2020","journal-title":"J Extracell Vesicles"},{"key":"B305","doi-asserted-by":"publisher","DOI":"10.2174\/1874357901812010134","article-title":"Exosome biogenesis and biological function in response to viral infections","volume":"12","author":"Crenshaw","year":"2018","journal-title":"Open Virol J"},{"key":"B306","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.00057","article-title":"The regulatory effects of paeoniflorin and its derivative paeoniflorin-6\u2019-O-benzene sulfonate Cp-25 on inflammation and immune diseases","volume":"10","author":"Tu","year":"2019","journal-title":"Front Pharmacol"},{"key":"B307","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/0272-0590(90)90160-l","article-title":"Refinement of long-term toxicity and carcinogenesis studies","volume":"15","author":"Rao","year":"1990","journal-title":"Fundam Appl Toxicol"},{"key":"B308","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e35343","article-title":"Poly (I:C) increases the expression of galectin 1, 3, 9 and Hgf genes in exosomes isolated from human Wharton\u2019s jelly mesenchymal stem cells","volume":"10","author":"Abbaspour","year":"2024","journal-title":"Heliyon"},{"key":"B309","doi-asserted-by":"publisher","DOI":"10.7150\/thno.41580","article-title":"Progress, opportunity, and perspective on exosome isolation - efforts for efficient exosome-based theranostics","volume":"10","author":"Yang","year":"2020","journal-title":"Theranostics"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1543702\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T05:30:48Z","timestamp":1747114248000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1543702\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,13]]},"references-count":309,"alternative-id":["10.3389\/fimmu.2025.1543702"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1543702","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,13]]},"article-number":"1543702"}}